ReviewJournal of personalized medicine2019
Genetic Testing to Guide Risk-Stratified Screens for Breast Cancer.
Review in Journal of personalized medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Methodologies underpinning polygenic risk scores estimation: a comprehensive overview.Human genetics · 2024Review
- Selection, optimization and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse US populations.Nature medicine · 2024Article
- Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel.Journal of medical genetics · 2023Article
- Evaluation of a genetic risk score computed using human chromosomal-scale length variation to predict breast cancer.Human genomics · 2023Article
- Investigation of germline variants in Bahraini women with breast cancer using next-generation sequencing based-multigene panel.PloS one · 2023Article
- Artificial intelligence and imaging for risk prediction of pancreatic cancer: a narrative review.Chinese clinical oncology · 2022Review
- Surgical Management of Hereditary Breast Cancer.Genes · 2021Review
- Review
- Referencing BRCA in hereditary cancer risk discussions: In search of an anchor in a sea of uncertainty.Journal of genetic counseling · 2020Article
- Understanding polygenic models, their development and the potential application of polygenic scores in healthcare.Journal of medical genetics · 2020Review
- Disparities in Genetic Testing and Care among Black women with Hereditary Breast Cancer.Current breast cancer reports · 2020Article
- Update on multi-gene panel testing and communication of genetic test results.The breast journal · 2020Article
- The promise of single-cell mechanophenotyping for clinical applications.Biomicrofluidics · 2020Article
- Healthcare Utilization and Costs after Receiving a PositiveJournal of personalized medicine · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Breast cancer screening modalities and guidelines continue to evolve and are increasingly based on risk factors, including genetic risk and a personal or family history of cancer. Here, we review genetic testing of high-penetrance hereditary breast and ovarian cancer genes, including
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.